These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26487580)

  • 1. Metabolic phenotyping of human blood plasma: a powerful tool to discriminate between cancer types?
    Louis E; Adriaensens P; Guedens W; Vanhove K; Vandeurzen K; Darquennes K; Vansteenkiste J; Dooms C; de Jonge E; Thomeer M; Mesotten L
    Ann Oncol; 2016 Jan; 27(1):178-84. PubMed ID: 26487580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Lung Cancer through Metabolic Changes Measured in Blood Plasma.
    Louis E; Adriaensens P; Guedens W; Bigirumurame T; Baeten K; Vanhove K; Vandeurzen K; Darquennes K; Vansteenkiste J; Dooms C; Shkedy Z; Mesotten L; Thomeer M
    J Thorac Oncol; 2016 Apr; 11(4):516-23. PubMed ID: 26949046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The plasma glutamate concentration as a complementary tool to differentiate benign PET-positive lung lesions from lung cancer.
    Vanhove K; Giesen P; Owokotomo OE; Mesotten L; Louis E; Shkedy Z; Thomeer M; Adriaensens P
    BMC Cancer; 2018 Sep; 18(1):868. PubMed ID: 30176828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualification and Verification of Serological Biomarker Candidates for Lung Adenocarcinoma by Targeted Mass Spectrometry.
    Wu HY; Goan YG; Chang YH; Yang YF; Chang HJ; Cheng PN; Wu CC; Zgoda VG; Chen YJ; Liao PC
    J Proteome Res; 2015 Aug; 14(8):3039-50. PubMed ID: 26120931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum free fatty acid biomarkers of lung cancer.
    Liu J; Mazzone PJ; Cata JP; Kurz A; Bauer M; Mascha EJ; Sessler DI
    Chest; 2014 Sep; 146(3):670-679. PubMed ID: 24743744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease.
    Szpechcinski A; Chorostowska-Wynimko J; Struniawski R; Kupis W; Rudzinski P; Langfort R; Puscinska E; Bielen P; Sliwinski P; Orlowski T
    Br J Cancer; 2015 Jul; 113(3):476-83. PubMed ID: 26125447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of acute-phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer.
    Dowling P; Clarke C; Hennessy K; Torralbo-Lopez B; Ballot J; Crown J; Kiernan I; O'Byrne KJ; Kennedy MJ; Lynch V; Clynes M
    Int J Cancer; 2012 Aug; 131(4):911-23. PubMed ID: 21953030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic phenotyping of human plasma by
    Louis E; Cantrelle FX; Mesotten L; Reekmans G; Bervoets L; Vanhove K; Thomeer M; Lippens G; Adriaensens P
    Magn Reson Chem; 2017 Aug; 55(8):706-713. PubMed ID: 28061019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a three-miRNA signature as a blood-borne diagnostic marker for early diagnosis of lung adenocarcinoma.
    Wang Y; Zhao H; Gao X; Wei F; Zhang X; Su Y; Wang C; Li H; Ren X
    Oncotarget; 2016 May; 7(18):26070-86. PubMed ID: 27036025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNA-339-5p and -21 in plasma as an early detection predictors of lung adenocarcinoma.
    Sun Y; Mei H; Xu C; Tang H; Wei W
    Pathol Res Pract; 2018 Jan; 214(1):119-125. PubMed ID: 29103767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of metabolomic blood biomarkers for detection of adenocarcinoma lung cancer.
    Fahrmann JF; Kim K; DeFelice BC; Taylor SL; Gandara DR; Yoneda KY; Cooke DT; Fiehn O; Kelly K; Miyamoto S
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1716-23. PubMed ID: 26282632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential erythrocyte phospholipid fatty acid biomarkers of advanced lung adenocarcinoma, squamous cell lung carcinoma, and small cell lung cancer.
    Sánchez-Rodríguez P; Rodríguez MC; Sánchez-Yagüe J
    Tumour Biol; 2015 Jul; 36(7):5687-98. PubMed ID: 25702090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
    Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM
    Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic profiling of type 1 diabetes mellitus in children and adolescents: a case-control study.
    Bervoets L; Massa G; Guedens W; Louis E; Noben JP; Adriaensens P
    Diabetol Metab Syndr; 2017; 9():48. PubMed ID: 28674557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Circulatory miRNA-21 as an Efficient Non-Invasive Biomarker for the Screening of Lung Cancer Patients.
    Abu-Duhier FM; Javid J; Sughayer MA; Mir R; Albalawi T; Alauddin MS
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2607-2611. PubMed ID: 30256067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients.
    Farias E; Ranuncolo S; Cresta C; Specterman S; Armanasco E; Varela M; Lastiri J; Pallotta MG; Bal de Kier Joffe E; Puricelli L
    Int J Cancer; 2000 Jul; 89(4):389-94. PubMed ID: 10956415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A plasma metabolite panel as biomarkers for early primary breast cancer detection.
    Yuan B; Schafferer S; Tang Q; Scheffler M; Nees J; Heil J; Schott S; Golatta M; Wallwiener M; Sohn C; Koal T; Wolf B; Schneeweiß A; Burwinkel B
    Int J Cancer; 2019 Jun; 144(11):2833-2842. PubMed ID: 30426507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential diagnostic value of miR-155 in serum from lung adenocarcinoma patients.
    Gao F; Chang J; Wang H; Zhang G
    Oncol Rep; 2014 Jan; 31(1):351-7. PubMed ID: 24190459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the ability of proton nuclear magnetic resonance spectroscopy of human plasma to differentiate between controls and breast cancer patients.
    Moreno A; Escrich E; Prats M; Benito N; Alonso J; Arús C
    Oncology; 1993; 50(2):110-5. PubMed ID: 8383828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma phospholipids fatty acids, dietary fatty acids, and breast cancer risk.
    Bassett JK; Hodge AM; English DR; MacInnis RJ; Giles GG
    Cancer Causes Control; 2016 Jun; 27(6):759-73. PubMed ID: 27146840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.